Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05645809

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery

Conditions: Laparoscopic Hysterectomy

Sex: Female
Ages: 19 Years – N/A
Phase: NA
Enrollment: 98
Sponsor: Samyang Biopharmaceuticals Corporation

Location: Korea, Republic of

Summary

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture Compared to Quill MonodermTM Suture in Laparoscopic Surgery

Eligibility Criteria

Inclusion Criteria:1. Patients scheduled for hysterectomy by laparoscopic surgeryPatients who are scheduled to undergo hysterectomy after being diagnosed with benign tumors in the uterus, including uterine myoma, according to the medical judgment of the investigatorLaparoscopic surgery includes general laparoscopic surgery and robotic surgery.)Exclusion Criteria:Patients with contaminated woundsDiseases that may affect wound healingWhen gynecological malignancy or intra-abdominal metastasis is confirmed at the time of enrollment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05645809). StuddyBuddy aggregates publicly available trial information.